@HPEPublicHealth This is great. Would you be able to confirm it’s the XBB monovalent available and what criteria you are using for high risk? Thank you!
@gomindshine1 @andryou@ONThealth It looks like @HPEPublicHealth isn’t going to run any vaccine clinics this fall. They are telling people to go to pharmacies.
@andryou@TheReSisters2@HPEPublicHealth has an update. Due to the labour dispute just ending, they won’t be running vaccine clinics until November 😡. https://t.co/9uITRiC2Tk
@apsmunro@DocDominik Important context: The investigators were also simultaneously involved in lawsuits trying to restrict HCW N95 use while this study was running.
@mjb302 He had time to speak to a local paper that wasn’t going to challenge or critique the research. How many N95’s could hospitals have bought with $1 million? https://t.co/OcwAEK4ucC
@KevinHedges15 This @CIDRAP piece incorporates solid critique of the poorly designed trial and wonder how @McMasterU, the capital of evidence based medicine, could stand behind it (and @AnnalsofIM to publish without more context)